In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody

Cancer Immunology, Immunotherapy

Volumn 50, Issue 1, 2001, Pages 51-59

  Roovers, Rob C ^a   van der Linden, Edith ^a   de Bruïne, Adriaan P ^b   Arends, Jan Willem ^a   Hoogenboom, Hennie R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CROSS REACTING ANTIBODY; EPITHELIAL CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; BACTERIOPHAGE; CANCER IMMUNOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; CROSS REACTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SOLID TUMOR;

AMINO ACID SEQUENCE; ANTIBODIES, BISPECIFIC; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS; CROSS REACTIONS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTHERAPY; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY;

EID: 0035094488     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000160     Document Type: Article

References (53)

1. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies
2. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu
3. Novel tetravalent and bispecific IgG-like antibody molecules combining singlechain diabodies with the immunoglobulin gamma 1 Fc or CH3 region
4. The biology of the 17-1A antigen (Ep-CAM)
5. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent
6. Periodate oxidation of carbohydrates
7. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies
8. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer
9. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinomaassociated antigen in patients
10. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
11. Human anti-self antibodies with high specificity from phage display libraries
12. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A
13. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
14. Selection of phage antibodies by binding affinity. Mimicking affinity maturation
15. Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies
16. Site-directed mutagenisis by overlap extension using the polymerase chain reaction
17. Multi-subunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains
18. Shedding of the soluble form of CD30 from the Hodgkinanalogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4)
19. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts
20. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments
21. Triabodies: Single chain Fv fragments without a linker form trivalent trimers
22. The antiglobulin response to therapeutic antibodies
23. Radioimmunodetection of human small cell lung cancer xenografts in the nude rat using 111In-labeled monoclonal antibody MOC-31
24. Single-chain Fv fragments of antineuraminidase antibody NC10 containing five and ten-residue linkers form dimers and with zero-residue linker a trimer
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule
27. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins
28. By-passing immunization. Human antibodies from V-gene libraries displayed on phage
29. Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display
30. Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer
31. An Hsp70-like protein in the ER: Identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein
32. High-affinity antigen binding by chelating recombinant antibodies (CRAbs)
33. Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors
34. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries
35. Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma - Long-lasting, complete remissions can be induced
36. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
37. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
38. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody
39. High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting
40. A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: Clinical and immunological data
41. Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody
42. DNA sequencing with chain-terminating inhibitors
43. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens
44. Proceedings of the First International Workshop on Small-Cell Lung-Cancer Antigens
45. Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells
46. Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen
47. Design and application of diabodies, triabodies and tetrabodies for cancer targeting
48. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library
49. Rhenium-186-labeled chimeric antibody NR-LU-13: Pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10
50. Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies
51. Making antibodies by phage display technology
52. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation